Researchers continue to excited about this new drug, a innovative dual treatment showing significant data in initial trials for weight management. It acts by impacting two systems: GLP-1 and GIP, that , when engaged , assist control hunger and enhance calorie burn. Initial reports indicate substantial body loss and possible benefits for patients st